Exel Inc.November 25, 2024

FDA 483 - Exel Inc. - November 25, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Exel Inc.

Record Details

An FDA inspection of Exel Inc. dba DHL Supply Chain (USA) in Lockbourne, OH, revealed multiple significant deficiencies in their quality systems for repackaged OTC drug products. The firm lacked adequate written procedures for production controls, investigations, annual product reviews, labeling, cleaning, and maintenance. These issues indicate a broad failure to adhere to good manufacturing practices, impacting product quality and control.

Company: Exel Inc.
Inspection Date: November 25, 2024
Product Type: Drugs
Office: Cincinnati District Office
Person: Ucheabuchi C. Chudi-nwankwor

Open in Dashboard

ID · 242f2567-2e91-4359-8b6c-e4ca6ec41bc7